[1] Chromium — Fact Sheet for Health Professionals
National Institutes of Health, Office of Dietary Supplements.
View sourcePeople looking for natural blood sugar support supplements often encounter formulas built around minerals and botanicals studied for glucose metabolism, glycemic control and metabolic wellness. This guide explains what the human research says about several commonly used ingredients—and where the evidence has important limits.
Reviewed and updated: September 28, 2026
Blood sugar support supplements are dietary supplements formulated with vitamins, minerals or botanical extracts marketed to support healthy glucose metabolism, healthy blood sugar levels or broader metabolic wellness. They are not substitutes for diagnosis, prescribed medication, dietary treatment or medical care.
Searches such as blood sugar support supplements, natural blood sugar support supplements, glucose support supplements, herbal supplements for blood sugar support and ingredients for healthy glucose metabolism often lead to formulas containing chromium, Gymnema, green tea, ginseng and other plant extracts.
What matters is not simply whether an ingredient sounds “natural,” but whether it has relevant human research, whether the preparation and dose are disclosed, and whether the formula can interact with medications.
The studies below examined individual nutrients, botanicals or standardized preparations. They did not test Glyco Barrier as a finished formula.
| Ingredient | What has been studied | What the evidence suggests | Important limitation |
|---|---|---|---|
| Chromium / Chromium Picolinate | Carbohydrate metabolism and glycemic control | Human trials and meta-analyses exist, but results vary across populations, doses and study quality.[1][2] | Effects are not uniform and should not be generalized to every chromium-containing supplement. |
| Gymnema Sylvestre | Fasting glucose, post-meal glucose, HbA1c, insulin secretion and sensitivity | A 2021 meta-analysis reported changes in several glycemic markers; a randomized 2020 trial studied people with impaired glucose tolerance.[3][4] | Substantial heterogeneity, preparation differences and dose differences limit direct product-to-study comparisons. |
| Green Tea | Glycemic control in randomized trials | A meta-analysis found a small reduction in fasting glucose but no significant overall effect on fasting insulin or HbA1c.[5][6] | Evidence is mixed and concentrated extracts have their own safety considerations. |
| Ginseng | Fasting glucose and other glycemic outcomes | Meta-analysis of Panax trials reported modest effects on fasting glucose.[7][8] | Ginseng species and preparation matter; a label that says only “ginseng root” does not identify the studied species. |
| Maca | Broader metabolic and wellness outcomes | One black-maca trial reported lower glucose, while another study did not show a glucose difference.[9][10] | Current evidence is too limited to treat maca as a primary glucose-control ingredient. |
This is a common search question, but the scientifically supportable answer needs more precision than a yes-or-no claim.
Some trials and meta-analyses of individual ingredients have observed reductions or other changes in fasting glucose, post-meal glucose or HbA1c in specific populations. Gymnema has particularly direct glucose-focused research, while chromium has a longer research history in carbohydrate metabolism and glycemic control.
Research on one ingredient does not prove that every supplement containing that ingredient will produce the same outcome. Finished formulas may use different extracts, doses and ingredient combinations, and some products do not disclose enough information to compare them directly with study protocols.

Glyco Barrier is marketed as a liquid dietary supplement for healthy glucose metabolism and metabolic wellness. The public formula information reviewed identifies Chromium Picolinate and a 200 mg proprietary herbal blend that specifically names Gymnema Sylvestre, Ginseng Root, Green Tea Leaf Extract and Maca Root.[11]
Several of those ingredients have been studied individually in glucose-related human research. That makes their presence relevant when evaluating a blood sugar support formula, but it does not establish that Glyco Barrier itself will reproduce the outcomes reported in those studies.
The biggest evidence limitation is dose transparency: the public description states that the herbal blend totals 200 mg but does not disclose each botanical amount. That prevents a direct comparison between the finished formula and the doses used in the cited research.
Prefer ingredients with relevant human trials or systematic reviews, and read what the studies actually measured instead of assuming every “natural” ingredient has the same evidence.
An ingredient name alone is not enough. Species, extract type, standardization and dose can materially affect how closely a product resembles the preparations studied in clinical research.
Glucose-focused supplements deserve extra caution because some ingredients may interact with insulin, antidiabetes medicines, levothyroxine or other prescriptions.
NIH notes that chromium may have additive glucose-lowering effects when combined with insulin or antidiabetes medicines, potentially increasing hypoglycemia risk, and chromium picolinate may reduce levothyroxine absorption when taken at the same time.[1] Concentrated green tea products and some ginseng preparations also have documented safety and medication-interaction considerations.[6][8]
They are dietary supplements formulated with nutrients or botanicals marketed to support healthy glucose metabolism or blood sugar levels already within a healthy range. Evidence varies substantially by ingredient, dose, preparation and population.
Chromium and Gymnema sylvestre have human research focused on glycemic outcomes. Green tea and Panax ginseng also have clinical research, although findings are more mixed or context-dependent.
Some studies of individual ingredients have reported changes in fasting glucose, post-meal glucose or HbA1c in specific populations. Results are not uniform, and those findings cannot be generalized to every supplement or finished formula.
A 2021 systematic review and meta-analysis reported changes in several glycemic markers among people with type 2 diabetes, while a 2020 randomized trial studied Gymnema in people with impaired glucose tolerance. Study heterogeneity and preparation differences remain important limitations.
Chromium is involved in carbohydrate metabolism and has been studied in glycemic control. Clinical findings vary by population, baseline status, formulation, dose and study quality.
Potential interactions matter. Chromium may have additive glucose-lowering effects with insulin or antidiabetes medicines, and concentrated green tea or some ginseng preparations may also interact with medications. People using prescription medicines should discuss supplements with a qualified healthcare professional.
The public product description reviewed identifies Chromium Picolinate and names Gymnema Sylvestre, Ginseng Root, Green Tea Leaf Extract and Maca Root within a 200 mg proprietary herbal blend. Individual botanical amounts are not publicly disclosed in that description.
These sources concern individual ingredients, specific botanical preparations or safety information. They should not be interpreted as clinical evidence for the finished Glyco Barrier formula.
National Institutes of Health, Office of Dietary Supplements.
View sourceSuksomboon N, Poolsup N, Yuwanakorn A. Journal of Clinical Pharmacy and Therapeutics. 2014;39(3):292–306. DOI: 10.1111/jcpt.12147. PMID: 24635480.
View sourceDevangan S, Varghese B, Johny E, Gurram S, Adela R. Phytotherapy Research. 2021;35(12):6802–6812. DOI: 10.1002/ptr.7265. PMID: 34467577.
View sourceRandomized, double-blind, placebo-controlled clinical trial. Journal of Medicinal Food. 2020. PMID: 32460589.
View sourceXu R, Bai Y, Yang K, Chen G. Nutrition & Metabolism. 2020;17:56. DOI: 10.1186/s12986-020-00469-5. PMID: 32670385.
View sourceNational Center for Complementary and Integrative Health.
View sourceShishtar E, Sievenpiper JL, Djedovic V, et al. PLOS ONE. 2014;9(9):e107391. DOI: 10.1371/journal.pone.0107391. PMID: 25265315.
View sourceNational Center for Complementary and Integrative Health.
View sourceGonzales-Arimborgo C, et al. Pharmaceuticals (Basel). 2016;9(3):49. DOI: 10.3390/ph9030049. PMID: 27548190.
View sourceRandomized, double-blind, placebo-controlled crossover study. Climacteric. PMID: 24931003.
View sourceManufacturer/marketer product page reviewed September 2026. Used for formula and product-description statements; commercial claims are treated as manufacturer-reported.
View source